Form 4: Director Acquires LMAT Shares via Vesting

Bridget A Ross, a director at Lemaitre Vascular Inc., acquired 5 shares of common stock through the vesting of restricted and performance stock units.

Summary

• Bridget A Ross, a director at Lemaitre Vascular Inc. (LMAT), acquired a total of 5 shares of common stock.
• The shares were acquired on December 8, 2025, at a price of $0 per share, through the release of dividend equivalent rights.
• These rights were released in connection with the vesting of a restricted stock unit (RSU) award (2 shares) and a performance stock unit (PSU) award (3 shares), both originally granted on December 8, 2023.
• Following these transactions, Bridget A Ross directly beneficially owns 2,922 shares of Lemaitre Vascular Inc. common stock.

Sentiment

Score: 6

Explanation: The filing reports a routine acquisition of shares by a director through the vesting of previously granted equity awards. This is a neutral to slightly positive event as it increases insider ownership, aligning interests, but does not reflect a discretionary open market purchase.

Positives

• The acquisition of shares by a director, even through routine vesting, increases insider ownership and aligns management interests with those of shareholders.

Future Outlook

This filing, a routine insider transaction report, does not contain any forward-looking statements or guidance regarding the company's future outlook.

Industry Context

This is a routine insider transaction related to executive compensation and does not provide specific insights into broader industry trends or competitive positioning.

Stakeholder Impact

• Shareholders: A minor positive impact due to increased alignment of a director's interests with shareholder value through increased direct ownership.

Key Dates

Recommendation

This Form 4 reports a routine acquisition of shares by a director through the vesting of previously granted equity awards. While it slightly increases insider ownership, it does not indicate a significant change in the company's fundamentals or strategic direction to warrant a 'buy' or 'sell' recommendation based solely on this filing. The transaction is part of a pre-existing compensation plan.

Keywords

Lemaitre Vascular, LMAT, SEC Form 4, Insider Transaction, Stock Vesting, Restricted Stock Units, Performance Stock Units, Director Ownership